Molecular Markers for Long-term Survival in Stage IIIA (N2) NSCLC Patients.
Nastase A, Dima SO, Lupo A, Laszlo V, Tagett R, Draghici S, Georgescu ME, Nechifor A, Berbece S, Popescu I, Alifano M, Klepetko W, Grigoroiu M.
Nastase A, et al. Among authors: nechifor a.
Cancer Genomics Proteomics. 2022 Jan-Feb;19(1):94-104. doi: 10.21873/cgp.20306.
Cancer Genomics Proteomics. 2022.
PMID: 34949662
Free PMC article.